Universal Health Services stock has delivered a solid 34.7% return over the past three years, yet its current valuation checks still suggest the shares lean cheap rather than fully priced. That mix of steady longer term gains and a relatively attractive valuation score is drawing attention as the company absorbs its recent acquisition of Talkspace.
The issue now is whether Universal Health Services' current share price already reflects the benefits and risks of its expanding behavioral health footprint or if there is still a valuation gap for investors to consider.
Find out why Universal Health Services' -3.6% return over the last year is lagging behind its peers.
The P/E multiple is a useful way to look at Universal Health Services because it links the current share price directly to the earnings that support it. On this measure, Universal Health Services trades on about 6.6x earnings, which is well below the broader Healthcare industry average of 24.8x and also below the peer group average of 20.8x. That is a wide gap for a large, established hospital and behavioral health operator.
The tailored fair P/E ratio for Universal Health Services is around 19.9x, which reflects what investors might typically pay given its sector, profitability profile and risk factors. The current 6.6x is far under that level, which points to a sizeable discount relative to what the model suggests could be justified. Despite the recent US$835m Talkspace deal highlighting growth ambitions in virtual behavioral health, the market P/E still prices Universal Health Services at a lower level than those benchmarks imply.
On the P/E multiple, Universal Health Services stock currently appears undervalued.
See what the numbers say about this price — find out in our valuation breakdown.
Simply Wall St Narratives pick up where the Universal Health Services valuation puzzle leaves off by spelling out which growth, margin and earnings paths would need to hold for the stock to be worth materially more or less than today's price. They sit on the company’s Community page. Each one frames Universal Health Services' fair value as a thesis about the business that you can keep revisiting as new information comes through over time.
Community views on Universal Health Services sit far apart, with some readers focused on structural demand and others on policy and cost pressure.
Bull case: 24% undervalued
“Organizations that can offer structured, evidence-based treatment at scale are becoming increasingly vital to the healthcare ecosystem…”
Read the full Bull Case to see why Universal Health Services could be undervalued
Bear case: roughly fairly valued
“Beginning in 2028, recent Medicaid legislation will sharply reduce Universal Health Services' supplemental payment benefits by approximately $360 million to $400 million annually by 2032, directly cutting into both net revenues and EBITDA growth and exposing the company to ongoing state-by-state policy uncertainty…”
Read the full Bear Case to see why Universal Health Services could be overvalued
Do you think there's more to the story for Universal Health Services? Head over to our Community to see what others are saying!
Universal Health Services screens as undervalued on market multiples, with the current P/E well below both sector averages and its tailored fair ratio. That gap will only matter to you if the company can execute on Talkspace integration and maintain earnings quality across its hospital and behavioral health operations. The crux of the debate is whether the discount reflects temporary caution around policy and virtual care risks, or a more permanent reset in how investors value the business. Your view on that single question is likely to drive whether Universal Health Services belongs on your watchlist.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com